Printer Friendly

ROBERTS PHARMACEUTICAL ACQUIRES TWO MARKETED NON-PRESCRIPTION PRODUCTS FROM UPJOHN

 ROBERTS PHARMACEUTICAL ACQUIRES TWO MARKETED
 NON-PRESCRIPTION PRODUCTS FROM UPJOHN
 EATONTOWN, N.J., Dec. 19 /PRNewswire/ -- Roberts Pharmaceutical Corporation (NASDAQ: RPCX) today announced that it has purchased two non-prescription drug products from the Upjohn Company (NYSE: UPJ). The products acquired are MYCIGUENT and BACIGUENT, two established topical first aid products used to prevent superficial skin infections. This is the second product acquisition transaction completed by Roberts with Upjohn. In September 1990, Roberts purchased from Upjohn all rights for several professionally promoted proprietary brands in the U.S., Canada, U.K. and Republic of Ireland, including the Cheracol line of cough/cold products.
 Roberts CEO, Robert Vukovich, commented on the new acquisition: "Although the sales of these two non-prescription pharmaceuticals will not be material to our overall financial performance, these well established brands will make a contribution to our growing OTC business as the products complement and balance our current line of dermatologicals which include our prescription product Topicycline, and our non-prescription products Clocream, Clomycin, and Clocort."
 Thomas M. Laughlin, vice president and general manager for the Upjohn Company Consumer Products division commented, "Upjohn Consumer Products continues to position itself to better focus its resources on current and future priorities and opportunities."
 Roberts Pharmaceutical Corporation is engaged in the business of acquiring, developing and marketing human pharmaceuticals in the United States and abroad. The company is developing late stage pharmaceuticals for the treatment of cancer, respiratory disease, endocrine disorders, pain management, cardiovascular and urologic conditions. Roberts currently markets a line of prescription and non-prescription pharmaceuticals in the United States and abroad.
 The Upjohn Company is a worldwide, research-based provider of human health care products, animal health products, agronomic and vegetable seeds and specialty chemicals. Headquartered in Kalamazoo, Mich., the company has been dedicated to improving health and nutrition for more than a century.
 -0- 12/19/91
 /CONTACT: Anthony P. Maris of Roberts Pharmaceutical, 908-389-1182, or Jeff Palmer of Upjohn Company, 616-323-6902/
 (RPCX UPJ) CO: Roberts Pharmaceutical Corporation; Upjohn Company ST: New Jersey, Michigan IN: MTC SU: TNM


SH-OS -- NY028 -- 3827 12/19/91 11:06 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 19, 1991
Words:345
Previous Article:$18,000 OF DECOMPOSED SCALLOPS SEIZED BY FEDERAL MARSHALS
Next Article:HCA ANNOUNCES COMPLETION OF ITS PENDING TRANSACTION WITH HEALTHTRUST AND REDEMPTION OF ITS 17 1/2 PERCENT EXCHANGE DEBENTURES
Topics:


Related Articles
ROBERTS PHARMACEUTICALS ANNOUNCES SIGNING OF MERGER AGREEMENT WITH HAUCK PHARMACEUTICALS
ROBERTS PHARMACEUTICALS ANNOUNCES ACQUISITION OF THREE MARKETED U.K. AND IRISH BRANDS FROM BOEHRINGER INGELHEIM
ROBERTS PHARMACEUTICAL ANNOUNCES ACQUISITION OF CURRENTLY MARKETED ANTI-PARKINSON DRUG FROM NORWICH EATON PHARMACEUTICALS
YAMANOUCHI TO PURCHASE EQUITY POSITION IN ROBERTS PHARMACEUTICALS
ROBERTS PHARMACEUTICAL CORPORATION TO ACQUIRE NATIONAL CLINICAL RESEARCH CENTERS
ROBERTS PHARMACEUTICALS COMPLETES ACQUISITION OF HAUCK PHARMACEUTICALS
ROBERTS PHARMACEUTICAL ACQUIRES MARKETED RESPIRATORY DRUG PRODUCT LINE FOR U.K. AND IRISH MARKETS FROM GALEN PHARMACEUTICALS
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES PRODUCT ACQUISITION AGREEMENT WITH BRISTOL-MYERS SQUIBB
ROBERTS PHARMACEUTICAL CORPORATION COMPLETES PRODUCT ACQUISITION FROM GLAXO CANADA INC.
ROBERTS PHARMACEUTICAL CORPORATION COMPLETES ACQUISITION OF U.S. AND CANADIAN PRODUCT LINES FROM BRISTOL-MYERS SQUIBB

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters